View in EDS HTML Full Text PDF Full Text

Determinants of the Financial Impact of Orphan Drugs in Italy: Differences Between Expected and Observed Pharmaceutical Expenditure.

Saved in:
Bibliographic Details
Title: Determinants of the Financial Impact of Orphan Drugs in Italy: Differences Between Expected and Observed Pharmaceutical Expenditure.
Authors: Mennini FS; Departments of Healthcare Planning, Medical Devices, Pharmaceuticals, and Policies in Support of the National Health Service, Italian Ministry of Health, Rome, Italy., Cicchetti A; Faculty of Economics, Economic Evaluation and HTA, CEIS, University of Rome 'Tor Vergata', Rome, Italy., Sciattella P; Department of Healthcare Planning, Italian Ministry of Health, Rome, Italy. paolo.sciattella@uniroma2.it., Rumi F; Graduate School of Health Economics and Management (ALTEMS), Università Cattolica del Sacro Cuore, Rome, Italy., Zanuzzi M; Italian Medicines Agency, Rome, Italy., Carletto A; Italian Medicines Agency, Rome, Italy., Sammarco A; Italian Medicines Agency, Rome, Italy., Romano F; Italian Medicines Agency, Rome, Italy., Russo P; Italian Medicines Agency, Rome, Italy.
Source: Drugs - real world outcomes [Drugs Real World Outcomes] 2025 Mar; Vol. 12 (1), pp. 25-33. Date of Electronic Publication: 2024 Dec 07.
Publication Type: Journal Article
Journal Info: Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101658456 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2199-1154 (Print) Linking ISSN: 21989788 NLM ISO Abbreviation: Drugs Real World Outcomes Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39644444
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Determinants of the Financial Impact of Orphan Drugs in Italy: Differences Between Expected and Observed Pharmaceutical Expenditure.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mennini+FS%22">Mennini FS</searchLink>; Departments of Healthcare Planning, Medical Devices, Pharmaceuticals, and Policies in Support of the National Health Service, Italian Ministry of Health, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Cicchetti+A%22">Cicchetti A</searchLink>; Faculty of Economics, Economic Evaluation and HTA, CEIS, University of Rome 'Tor Vergata', Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Sciattella+P%22">Sciattella P</searchLink>; Department of Healthcare Planning, Italian Ministry of Health, Rome, Italy. paolo.sciattella@uniroma2.it.<br /><searchLink fieldCode="AU" term="%22Rumi+F%22">Rumi F</searchLink>; Graduate School of Health Economics and Management (ALTEMS), Università Cattolica del Sacro Cuore, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Zanuzzi+M%22">Zanuzzi M</searchLink>; Italian Medicines Agency, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Carletto+A%22">Carletto A</searchLink>; Italian Medicines Agency, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Sammarco+A%22">Sammarco A</searchLink>; Italian Medicines Agency, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Romano+F%22">Romano F</searchLink>; Italian Medicines Agency, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Russo+P%22">Russo P</searchLink>; Italian Medicines Agency, Rome, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101658456%22">Drugs - real world outcomes</searchLink> [Drugs Real World Outcomes] 2025 Mar; Vol. 12 (1), pp. 25-33. <i>Date of Electronic Publication: </i>2024 Dec 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+International+Publishing%22">Springer International Publishing </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101658456 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2199-1154 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221989788%22">21989788 </searchLink><i>NLM ISO Abbreviation: </i>Drugs Real World Outcomes <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39644444
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40801-024-00463-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 25
    Titles:
      – TitleFull: Determinants of the Financial Impact of Orphan Drugs in Italy: Differences Between Expected and Observed Pharmaceutical Expenditure.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mennini FS
      – PersonEntity:
          Name:
            NameFull: Cicchetti A
      – PersonEntity:
          Name:
            NameFull: Sciattella P
      – PersonEntity:
          Name:
            NameFull: Rumi F
      – PersonEntity:
          Name:
            NameFull: Zanuzzi M
      – PersonEntity:
          Name:
            NameFull: Carletto A
      – PersonEntity:
          Name:
            NameFull: Sammarco A
      – PersonEntity:
          Name:
            NameFull: Romano F
      – PersonEntity:
          Name:
            NameFull: Russo P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2025 Mar
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2199-1154
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Drugs - real world outcomes
              Type: main
ResultId 1